Health Diaries > Prescription Drug Watch
FDA Orders Label Changes for Dexedrine
The FDA has asked pharmaceutical company GlaxoSmithKline to add a warning to ADHD drug Dexedrine alerting patients to possible risk of heart problems when taking the drug.
The warning describes some instances of sudden death in children and teens with structural cardiac abnormalities or other heart problems. It also mentions various potential psychological side effects, including hallucinations or delusional thinking.
ADHD Drug to Get Stronger Warning
Cardiovascular Safety Warning Added for Stimulants for ADHD
Filed under FDA, GlaxoSmithKline
